Indications and Usage Wegovy (semaglutide) injection is indicated in combination with a reduced calorie diet and increased physical activity: To reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight To reduce excess body weight and maintain weight reduction long term in: Adults and pediatric patients 12 years and older with obesity Adults with overweight in the presence of at least one weight-related comorbidity Wegovy (semaglutide) tablets are indicated in combination with a reduced calorie diet and increased physical activity to: Reduce the risk of major adverse cardiovascular (CV) events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight Reduce excess body weight and maintain weight reduction long term in adults with obesity or with overweight in the presence of at least one weight-related comorbidity Limitations of Use: Concomitant use of Wegovy tablets or Wegovy injection with other semaglutide-containing products or with any GLP-1 receptor agonist is not recommended References Wegovy [package insert]

Missing doses can significantly impact your treatment effectiveness, potentially delaying your weight loss results or blood sugar management
You specifically want Lifestyle Score, Community Rankings, streaks, and score-based motivation
The meteoric rise in the popularity of GLP-1 medications has created a breeding ground for online scams and the sale of unauthorized products, Roth said
Our team has fielded questions about this from labs across the country, so we decided it was time to put together a definitive resource for 2026, breaking down the science behind the scent and what it means for your work